Syncom Formulations (India) Limited (BOM:524470)

Market Cap	13.39B -20.1%
Revenue (ttm)	5.15B +56.9%
Net Income	630.52M +90.2%
EPS	0.63 +74.3%
Shares Out	940.00M
PE Ratio	22.76
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	190,224
Average Volume	214,183
Open	14.50
Previous Close	14.20
Day's Range	14.00 - 14.50
52-Week Range	11.52 - 23.46
Beta	0.57
RSI	58.47
Earnings Date	Feb 12, 2026

About BOM:524470

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms. It also provides life care, evolve, an...

• Industry: Pharmaceutical Preparations
• Founded: 1988
• Employees: 744
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524470

Financial Performance

In fiscal year 2025, BOM:524470's revenue was 4.65 billion, an increase of 76.55% compared to the previous year's 2.63 billion. Earnings were 494.35 million, an increase of 95.28%.